Cyclophosphamide and whole organ transplantation in human beings.

PubWeight™: 5.24‹?› | Rank: Top 1%

🔗 View Article (PMC 2762737)

Published in Surg Gynecol Obstet on December 01, 1971


T E Starzl, C W Putnam, C G Halgrimson, G T Schroter, G Martineau, B Launois, J L Corman, I Penn, A S Booth, C G Groth, K A Porter

Articles citing this

Evolution of liver transplantation. Hepatology (1982) 19.54

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26

Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation (1993) 2.17

Randomised trialomania? The multicentre liver transplant trials of tacrolimus. Lancet (1995) 2.04

Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg (1979) 1.80

Factors in the Development of Liver Transplantation. Transplant Proc (1985) 1.74

Metabolic effects of hepatic replacement in Wilson's disease. Transplant Proc (1973) 1.73

Immunosuppression and other nonsurgical factors in the improved results of liver transplantation. Semin Liver Dis (1985) 1.62

Thoracic duct fistula and renal transplantation. Ann Surg (1979) 1.60

The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56

Drug development and testing in relation to cell migration and chimerism. Transplant Proc (1993) 1.52

Liver transplantation in the ciclosporin era. Prog Allergy (1986) 1.14

Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells. Am J Pathol (1993) 1.06

Cyclophosphamide for clinical renal and hepatic transplantation. Transplant Proc (1973) 1.04

The effect of microsomal enzyme inhibition on the immunosuppressive and toxic effects of cyclophosphamide. Clin Exp Immunol (1973) 1.01

The fate of failed renal homografts retained after retransplantation. Surg Gynecol Obstet (1973) 0.98

Kidney transplantation. Modern trends in kidney transplantation. Transplant Proc (1977) 0.97

Personal experience with orthotopic liver transplantation. Transplant Proc (1972) 0.96

Steps in immunosuppression for renal transplantation. Kidney Int Suppl (1983) 0.93

History of clinical transplantation. World J Surg (2000) 0.91

Personal reflections in transplantation. Surg Clin North Am (1978) 0.84

The Future of Xenotransplantation. Ann Surg (1992) 0.80

The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat. Clin Exp Immunol (1979) 0.77

Louv Med (1973) 0.75

Renal transplantation under cyclophosphamide. Transplant Proc (1972) 0.75

Proceedings: Transplantation of extrarenal organs. Proc Natl Cancer Conf (1972) 0.75

Articles cited by this


The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Human renal transplantation. I. Clinical experiences with six cases of renal homotransplantation. J Urol (1963) 3.35

Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues. Fed Proc (1967) 2.44

Cyclophosphamide therapy in Wegener's granulomatosis. N Engl J Med (1971) 2.33

Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome. Br Med J (1966) 2.31

Cyclophosphamide therapy in the nephrotic syndrome in childhood. Br Med J (1969) 1.99

Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89

Cyclophosphamide in the treatment of systemic lupus erythematosus. Br Med J (1966) 1.83

Cyclophosphamide and human organ transplantation. Lancet (1971) 1.77

Use of cyclophosphamide in an attempt to modify the canine renal homograft response. Nature (1963) 1.72


Immunosuppressive therapy of ocular inflammatory diseases. Arch Ophthalmol (1969) 1.29

Symposium on immunosuppressive drugs. Some biochemical effects of alkylating agents. Fed Proc (1967) 1.21

Cyclophosphamide therapy of peripheral uveitis. Arch Intern Med (1969) 1.15

"Refractory" thrombocytopenic purpura treated successfully with cyclophosphamide. JAMA (1971) 1.10

Cyclophosphamide in renal homotransplantation. Br J Urol (1966) 1.09


Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med (1994) 7.96

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26